Articles/Commentaries
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial by Thomas Louie, MD' Yoav Golan, MD., Sahil Khanna, MBBS, MS, et al. JAMA April 25, 2023
Updated: Apr 26
Articles/Commentaries
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial by Thomas Louie, MD' Yoav Golan, MD., Sahil Khanna, MBBS, MS, et al. JAMA April 25, 2023
Medical Journal Articles WHO Warns Against Artificial Sugars for Weight Loss by Emily Harris JAMA May 31 2023 Oral Semaglutide Led to Similar Weight Loss as Injection, Company Says by Emily Harris JAM
Medical Journal Articles Group A Streptococcal Meningitis With the M1UK Variant in the Netherlands by Boas C. L. van der Putten, PhD. Bart J. M. Vlaminckx, MD, PhD. Brechje de Gier, PhD, et al. JAMA M